Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/31961
Title: The Association of Oral Bisphosphonate Use With Mortality Risk Following a Major Osteoporotic Fracture in the United Kingdom: Population-Based Cohort Study
Authors: Abtahi, Shahab
Burden, Andrea M.
GEUSENS, Piet 
van Staa, Tjeerd
VAN DEN BERGH, Joop 
de Vries, Frank
Issue Date: 2020
Publisher: ELSEVIER SCIENCE INC
Source: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 21 (6) , p. 811 -816
Abstract: Bisphosphonates (BPs) might have extra benefits in reducing mortality because of their anti-atherosclerotic effects, but studies reported conflicting results. We investigated the association between oral BP use and mortality risk following a major osteoporotic fracture (MOF) in the United Kingdom.
Notes: de Vries, F (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Univ Weg 99, NL-3584 CG Utrecht, Netherlands.
f.devries@uu.nl
Other: de Vries, F (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Univ Weg 99, NL-3584 CG Utrecht, Netherlands. f.devries@uu.nl
Keywords: Intima-Media Thickness;Hip Fracture;Zoledronic Acid;Alendronate;Disease;Women;Calcification;Metaanalysis;Prevention;Men
Document URI: http://hdl.handle.net/1942/31961
ISSN: 1525-8610
e-ISSN: 1538-9375
DOI: 10.1016/j.jamda.2019.11.003
ISI #: WOS:000542142700017
Rights: 2019 AMDA - The Society for Post-Acute and Long-Term Care Medicine.
Category: A1
Type: Journal Contribution
Validations: ecoom 2021
Appears in Collections:Research publications

Show full item record

WEB OF SCIENCETM
Citations

9
checked on Apr 14, 2024

Page view(s)

60
checked on May 30, 2023

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.